Gossamer Bio accepts early tenders of USD 181.05 million 5% convertible notes in exchange offer

Gossamer Bio

Gossamer Bio

GOSS

0.00
  • Gossamer Bio accepted USD 181.05 million of 5% Convertible Senior Notes due 2027 in an exchange offer, reaching 90.53% participation.
  • Early settlement set for June 4, issuing USD 65.17 million of 7.5% Convertible Senior Secured First Lien Notes due 2030.
  • Consideration also includes 254,150,441 shares, 33,402,727 prefunded warrants, 135,789,000 purchase warrants.
  • Minimum tender condition cut to 90.5% from 98%; indenture amendments take effect at early settlement.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gossamer Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001728117-26-000045), on June 05, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.